| RS2510386025 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510386126 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510386166 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510386542 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510386943 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510387276 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2510393718 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2510396780 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510396866 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510396923 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510398841 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510398963 |
GAA
|
Health Risk |
Likely pathogenic |
— |
| RS2510399226 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510399260 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510399333 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510399942 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510399985 |
GAA
|
Health Risk |
Likely pathogenic |
— |
| RS2510400033 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510402002 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510402010 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510402131 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510402647 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510403029 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510404041 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510404093 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510404144 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510404152 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS2510404321 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510404334 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510404344 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510404506 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510404583 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510404705 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS2510404730 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510405069 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510405389 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2510407100 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2510407224 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2510469062 |
TMC6
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2510470459 |
KANSL1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2510473419 |
PIEZO2
|
Health Risk |
Likely pathogenic |
PIEZO2-related disorder, PIEZO2-related disorder |
| RS2510479553 |
GNAL
|
Health Risk |
Likely pathogenic |
Dystonia 25, Dystonia 25 |
| RS2510481195 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2510481313 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2510487229 |
ATP6V0A1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 104, Neurodevelopmental disorder with epilepsy and brain atrophy |
| RS2510489205 |
PIEZO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Arthrogryposis, distal |
| RS2510489906 |
TANC2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autistic features and language delay, with or without seizures |
| RS2510499866 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2510500842 |
KANSL1
|
Health Risk |
Pathogenic |
— |
| RS2510501074 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2510516321 |
TMC6
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2510535483 |
GNAL
|
Health Risk |
Pathogenic |
Dystonic disorder, Dystonic disorder |
| RS2510548443 |
TBCD
|
Health Risk |
Likely pathogenic |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS2510549477 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS2510609298 |
TANC2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2510610110 |
BPTF
|
Health Risk |
Likely pathogenic |
— |
| RS2510614539 |
ARSG
|
Health Risk |
Likely pathogenic |
Usher syndrome, type 4 |
| RS2510618048 |
RBFOX1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2510624241 |
TMC6
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS2510625479 |
GATA6
|
Health Risk |
Likely pathogenic |
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome, Pancreatic hypoplasia-diabetes-congenital heart disease syndrome |
| RS2510626008 |
GATA6
|
Health Risk |
Pathogenic |
Atrioventricular septal defect 5, Atrioventricular septal defect 5 |
| RS2510626075 |
GATA6
|
Health Risk |
Likely pathogenic |
GATA6-related disorder, GATA6-related disorder |
| RS2510626136 |
GATA6
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2510626168 |
GATA6
|
Health Risk |
Pathogenic |
Conotruncal heart malformations, Conotruncal heart malformations |
| RS2510626255 |
GATA6
|
Health Risk |
Pathogenic |
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome, Pancreatic hypoplasia-diabetes-congenital heart disease syndrome |
| RS2510627049 |
GATA6
|
Health Risk |
Pathogenic |
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome, Pancreatic hypoplasia-diabetes-congenital heart disease syndrome |
| RS2510629614 |
GATA6
|
Health Risk |
Pathogenic |
— |
| RS2510632394 |
GATA6
|
Health Risk |
Pathogenic |
— |
| RS2510632428 |
GATA6
|
Health Risk |
Pathogenic |
GATA6-related disorder, GATA6-related disorder |
| RS2510632551 |
TANC2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autistic features and language delay, with or without seizures |
| RS2510637127 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS2510637132 |
PIEZO2
|
Health Risk |
Likely pathogenic |
— |
| RS2510637362 |
PIEZO2
|
Health Risk |
Pathogenic |
— |
| RS2510643985 |
TBCD
|
Health Risk |
Likely pathogenic |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS2510648438 |
KANSL1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Koolen-de Vries syndrome |
| RS2510649349 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2510649581 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510649722 |
KANSL1
|
Health Risk |
Pathogenic |
— |
| RS2510649793 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510649972 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS2510650286 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510650296 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510650548 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510650554 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS2510652024 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510652026 |
NAGLU
|
Health Risk |
Likely pathogenic |
NAGLU-related disorder, NAGLU-related disorder |
| RS2510652114 |
NAGLU
|
Health Risk |
Likely pathogenic |
NAGLU-related disorder, NAGLU-related disorder |
| RS2510652118 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510652165 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510652171 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510652210 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510652219 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510653230 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510653298 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510653303 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS2510653397 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510653834 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS2510653897 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510653907 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS2510653910 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |